Indonesia to Follow Global Standards for Safe Covid-19 Vaccine Distribution

President Jokowi previously outlined the government’s swift move in distributing a coronavirus vaccine in Indonesia.

One reason is that Indonesia has been developing its own vaccine with the government in the final round of purchasing the vaccines from three producers: Cansino, G42/Sinopharm, and Sinovac.

However, all three manufacturers have yet to pass Phase 3 clinical trials.

Jokowi reiterated that the rush for a vaccine does not only apply to Indonesia, but to all countries as the global race for a coronavirus cure is in full gear.

The Indonesian President further explained that this global rush is to help their respective societies ward off the novel virus and restore individual economies.

Jokowi underlined that despite this rush, Indonesia’s residents will only be inoculated with a vaccine that has properly passed clinical trials to ensure that a potential coronavirus cure is safe and has no side effects.

Read also: Indonesia Highlights: President Jokowi Justifies Authorization of Untested Vaccines | General Election Commission Allows Ex-Corruptors to Run for Office | Walhi Slams Jurassic Park Project

“What we want to avoid is rushing in obtaining a vaccine that has no scientific data or from a manufacturer that has not prioritized safety standards. We cannot allow that to happen,” said Jokowi.

Jokowi has instructed his cabinet ministers to involve religious organizations in the country such as Muhammadiyah, Nahdlatul Ulama, and the Indonesian Ulema Council in socializing Indonesia’s Covid-19 vaccination plans.

Indonesia’s President has stressed the important role religious organizations have in elaborating on the benefits of a vaccine to the public.

(Writer: Muhammad Idris | Editor: Muhammad Idris)

Source: https://money.kompas.com/read/2020/10/28/080320626/jokowi-borong-vaksin-covid-19-yang-belum-lolos-uji-klinis-ini-kata-sri-mulyani?page=all#page2